ly2523355
Showing 1 - 7 of 7
Metastatic Breast Cancer Trial in United States (LY2523355, ixabepilone, pegfilgrastim)
Completed
- Metastatic Breast Cancer
- LY2523355
- +3 more
-
Fort Myers, Florida
- +11 more
Sep 9, 2019
Advanced Cancer, Metastatic Cancer Trial in Albuquerque, Philadelphia (LY2523355, pegfilgrastim)
Completed
- Advanced Cancer
- Metastatic Cancer
- LY2523355
- pegfilgrastim
-
Albuquerque, New Mexico
- +1 more
Aug 3, 2018
Small Cell Lung Cancer Trial in Korea, Republic of, Romania, United States (LY2523355, Granulocyte colony-stimulating factor
Completed
- Small Cell Lung Cancer
- LY2523355
- Granulocyte colony-stimulating factor (G-CSF)
-
Torrington, Connecticut
- +10 more
Sep 9, 2019
Advanced Cancer Trial in Nashville, San Antonio (pegfilgrastim, LY2523355)
Ovarian Cancer, Non Small Cell Lung Cancer, Prostate Cancer Trial in United States (LY2523355, pegfilgrastim)
Solid Tumors Trial in Tokyo (LY2523355)
Completed
- Solid Tumors
- LY2523355
-
Tokyo, Japan(unnamed)
Jan 25, 2013